NCT06057727
- Conditions
- Behavior, Behavior, Health, Flu, +9 more
- Locations
-
- University of Pennsylvania Health System Philadelphia, Pennsylvania, United States
- University of Washington Seattle, Washington, United States
Clinical trial condition
Orthomyxoviridae Infections
Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.
1,810 public trials
84 recruiting studies
Orthomyxoviridae Infections trial results
NCT04896086
- Conditions
- Infections, Influenza, Influenza, Human, +6 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06015282
- Conditions
- Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
- Locations
-
- Alliance for Multispecialty Research (AMR) Phoenix Tempe, Arizona, United States
- Baptist Health Center for Clinical Research Little Rock, Arkansas, United States
- Marvel Clinical Research Huntington Beach, California, United States
- Paradigm Clinical Research Center, LLC Redding, California, United States
NCT06062264
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
NCT05033782
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, COVID-19, +21 more
- Locations
-
- Neurology Department, Hopital de la Pitié Salpêtrière Paris, France
NCT05535777
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Los Angeles County Department of Health Services Los Angeles, California, United States
- University of California, Los Angeles Los Angeles, California, United States
NCT06103994
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Leof. Mesogeion 264, Athens, Cholargos, Greece
Completed
Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients
NCT03378479
- Conditions
- Aspergillosis, Aspergillosis; Pulmonary, Invasive (Etiology), Bacterial Infections and Mycoses, +8 more
- Locations
-
- AZ Sint Jan Bruges, Belgium
- UZ Gent Ghent, Belgium
- UZ Leuven Leuven, Belgium
- AZ Delta Roeselare, Belgium
Completed
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
NCT05027932
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT03694392
- Conditions
- Acute Myocardial Infarction, Brain Diseases, Cardiovascular Diseases, +19 more
- Locations
-
- Kaiser Permanente Northern California (entire region) Oakland, California, United States